Roosha Parikh, MD
Cardiovascular Disease · Roslyn, NYNPI 1043560626
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,540 of the $72,781 with a category attached, or 80.4%. Heartflow, Inc. accounts for 93.2% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $55,974, more than ten times the $972 reported in 2019. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $551.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$68K
- Siemens Medical Solutions USA, Inc.$2K
- Medtronic$956
- Boston Scientific$758
- Amgen$488
- Abbott$315
- plus $666 from 7 others
What the payments were for
- Consulting fees$2,1133%
- Speaking & faculty fees$58,54080%
- Grants$5001%
- Travel & lodging$7,31510%
- Food & beverage$4,3136%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 67 | $67,861 |
| Siemens Medical Solutions USA, Inc. | 2 | $1,737 |
| Medtronic(2 entities) | 12 | $956 |
| Boston Scientific | 5 | $758 |
| Amgen | 22 | $488 |
| Abbott | 7 | $315 |
| Cleerly, Inc. | 3 | $162 |
| Edwards Lifesciences | 2 | $114 |
| Philips North America LLC | 2 | $111 |
| Recor Medical Inc | 1 | $108 |
| Lantheus Medical Imaging, Inc. | 4 | $82 |
| Pfizer | 4 | $73 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,781 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Roslyn
- Aman ShahRoslyn$236K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.